| 年度 | 2025 |
|---|---|
| 全部作者 | 陈秉训 |
| 论文名称 | Ping-Hsun Chen*, 2025.10, 'How a Treatment Claim Without Reciting Safety and Efficacy Requirements May Survive the Disclosure Requirement Challenge: United Therapeutics Corp. v. Liquidia Technologies, Inc., ' Biotechnology Law Report, Vol.44, No.5, pp.279–280.(SCIE)(*为通讯作者) |
| 卷数 | 143181 |
| 发表日期 | 2025-10-01 |
